Genmab Expands Use of IDBS’ ActivityBase XE in Hybridoma Discovery

Guildford, United Kingdom, September 11, 2007 – IDBS, an industry leading provider of drug discovery data management solutions, today announced that Genmab BV (Utrecht, The Netherlands) has extended its use of ActivityBase Xtended Edition (ActivityBase XE) within its Hybridoma Discovery…